Teladoc Health, Inc. (0LDR.L)
USD 7.2
(1.62%)
USD 7.2
(1.62%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 2.06 Billion USD | 1.41% |
| 2022 | 2.03 Billion USD | 20.65% |
| 2021 | 1.68 Billion USD | -9.76% |
| 2020 | 1.87 Billion USD | 217.84% |
| 2019 | 588.8 Million USD | 14.16% |
| 2018 | 515.75 Million USD | 94.27% |
| 2017 | 265.48 Million USD | 264.68% |
| 2016 | 72.8 Million USD | 42.26% |
| 2015 | 51.17 Million USD | 31.97% |
| 2014 | 38.77 Million USD | 365.44% |
| 2013 | 8.33 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 2.02 Billion USD | -0.03% |
| 2024 Q1 | 2.03 Billion USD | -1.67% |
| 2024 Q2 | 2.02 Billion USD | -0.51% |
| 2023 Q3 | 2.03 Billion USD | 0.63% |
| 2023 Q4 | 2.06 Billion USD | 1.59% |
| 2023 FY | 2.06 Billion USD | 1.41% |
| 2023 Q1 | 2.01 Billion USD | -0.97% |
| 2023 Q2 | 2.02 Billion USD | 0.17% |
| 2022 Q2 | 2.01 Billion USD | 3.51% |
| 2022 Q1 | 1.94 Billion USD | 15.45% |
| 2022 Q4 | 2.03 Billion USD | -0.67% |
| 2022 FY | 2.03 Billion USD | 20.65% |
| 2022 Q3 | 2.05 Billion USD | 1.64% |
| 2021 Q4 | 1.68 Billion USD | 1.43% |
| 2021 Q2 | 1.61 Billion USD | -8.15% |
| 2021 Q3 | 1.66 Billion USD | 3.41% |
| 2021 FY | 1.68 Billion USD | -9.76% |
| 2021 Q1 | 1.75 Billion USD | -6.34% |
| 2020 Q4 | 1.87 Billion USD | 53.61% |
| 2020 FY | 1.87 Billion USD | 217.84% |
| 2020 Q3 | 1.21 Billion USD | 8.4% |
| 2020 Q2 | 1.12 Billion USD | 86.42% |
| 2020 Q1 | 602.9 Million USD | 2.39% |
| 2019 Q3 | 574.69 Million USD | 2.13% |
| 2019 Q1 | 550.06 Million USD | 6.65% |
| 2019 Q2 | 562.7 Million USD | 2.3% |
| 2019 FY | 588.8 Million USD | 14.16% |
| 2019 Q4 | 588.8 Million USD | 2.46% |
| 2018 Q2 | 500.52 Million USD | 87.71% |
| 2018 Q3 | 507.41 Million USD | 1.38% |
| 2018 FY | 515.75 Million USD | 94.27% |
| 2018 Q4 | 515.75 Million USD | 1.64% |
| 2018 Q1 | 266.65 Million USD | 0.44% |
| 2017 Q2 | 274.77 Million USD | 289.63% |
| 2017 Q1 | 70.52 Million USD | -3.13% |
| 2017 FY | 265.48 Million USD | 264.68% |
| 2017 Q4 | 265.48 Million USD | -38.85% |
| 2017 Q3 | 434.14 Million USD | 58.0% |
| 2016 Q1 | 48.38 Million USD | -5.46% |
| 2016 Q2 | 51.93 Million USD | 7.34% |
| 2016 FY | 72.8 Million USD | 42.26% |
| 2016 Q4 | 72.8 Million USD | 2.58% |
| 2016 Q3 | 70.96 Million USD | 36.66% |
| 2015 Q4 | 51.17 Million USD | 0.85% |
| 2015 Q3 | 50.74 Million USD | -22.01% |
| 2015 Q2 | 65.06 Million USD | 41.46% |
| 2015 Q1 | 45.99 Million USD | 18.61% |
| 2015 FY | 51.17 Million USD | 31.97% |
| 2014 Q4 | 38.77 Million USD | 0.0% |
| 2014 FY | 38.77 Million USD | 365.44% |
| 2014 Q1 | - USD | 0.0% |
| 2013 FY | 8.33 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Phreesia, Inc. | 119.63 Million USD | -1627.152% |
| Accuray Incorporated | 423.54 Million USD | -387.86% |
| Align Technology, Inc. | 2.45 Billion USD | 15.778% |
| Elevance Health Inc. | 69.52 Billion USD | 97.028% |
| AxoGen, Inc. | 101.16 Million USD | -1942.561% |
| Boston Scientific Corporation | 15.6 Billion USD | 86.76% |
| CVS Health Corporation | 173.09 Billion USD | 98.806% |
| Cardinal Health, Inc. | 48.33 Billion USD | 95.725% |
| Centene Corporation | 58.68 Billion USD | 96.479% |
| DaVita Inc. | 14.87 Billion USD | 86.11% |
| HCA Healthcare, Inc. | 55.15 Billion USD | 96.253% |
| Hologic, Inc. | 4.02 Billion USD | 48.676% |
| Humana Inc. | 30.74 Billion USD | 93.28% |
| IDEXX Laboratories, Inc. | 1.77 Billion USD | -16.385% |
| Laboratory Corporation of America Holdings | 8.83 Billion USD | 76.611% |
| Masimo Corporation | 1.67 Billion USD | -23.236% |
| McKesson Corporation | 69.04 Billion USD | 97.007% |
| Patterson Companies, Inc. | 1.89 Billion USD | -9.039% |
| Quest Diagnostics Incorporated | 7.6 Billion USD | 72.826% |
| ResMed Inc. | 2 Billion USD | -2.885% |
| Henry Schein, Inc. | 5.42 Billion USD | 61.876% |
| Universal Health Services, Inc. | 8.15 Billion USD | 74.662% |
| Veeva Systems Inc. | 1.26 Billion USD | -63.202% |
| Baxter International Inc. | 19.8 Billion USD | 89.568% |
| Becton, Dickinson and Company | 26.98 Billion USD | 92.343% |
| Intuitive Surgical, Inc. | 2.04 Billion USD | -1.081% |
| Danaher Corporation | 30.99 Billion USD | 93.334% |
| Stryker Corporation | 21.31 Billion USD | 90.308% |
| Medtronic plc | 39.56 Billion USD | 94.777% |